Middle East Healthcare Company SJSC
SAU:4009

Watchlist Manager
Middle East Healthcare Company SJSC Logo
Middle East Healthcare Company SJSC
SAU:4009
Watchlist
Price: 68 SAR -1.45% Market Closed
Market Cap: 3.9B SAR

Intrinsic Value

The intrinsic value of one Middle East Healthcare Company SJSC stock under the Base Case scenario is hidden SAR. Compared to the current market price of 68 SAR, Middle East Healthcare Company SJSC is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Middle East Healthcare Company SJSC Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Middle East Healthcare Company SJSC

Intrinsic Value History
Dive into the past to invest in the future

Middle East Healthcare Company SJSC looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Middle East Healthcare Company SJSC is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Middle East Healthcare Company SJSC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Middle East Healthcare Company SJSC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Middle East Healthcare Company SJSC.

Explain Valuation
Compare Middle East Healthcare Company SJSC to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about Middle East Healthcare Company SJSC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Middle East Healthcare Company SJSC

Current Assets 2.1B
Cash & Short-Term Investments 70m
Receivables 1.9B
Other Current Assets 154m
Non-Current Assets 3.1B
Long-Term Investments 66.9m
PP&E 3B
Intangibles 47.7m
Other Non-Current Assets -100
Current Liabilities 1.4B
Accounts Payable 255.2m
Accrued Liabilities 233.7m
Short-Term Debt 714.7m
Other Current Liabilities 180.2m
Non-Current Liabilities 2B
Long-Term Debt 1.6B
Other Non-Current Liabilities 429.5m
Efficiency

Free Cash Flow Analysis
Middle East Healthcare Company SJSC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Middle East Healthcare Company SJSC

Revenue
3B SAR
Cost of Revenue
-1.9B SAR
Gross Profit
1.2B SAR
Operating Expenses
-755.7m SAR
Operating Income
402m SAR
Other Expenses
-30.8m SAR
Net Income
371.2m SAR
Fundamental Scores

Profitability Score
Profitability Due Diligence

Middle East Healthcare Company SJSC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive ROE
Healthy Gross Margin
ROIC is Increasing
hidden
Profitability
Score

Middle East Healthcare Company SJSC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Middle East Healthcare Company SJSC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Average Altman Z-Score
hidden
Solvency
Score

Middle East Healthcare Company SJSC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Middle East Healthcare Company SJSC

Wall Street analysts forecast Middle East Healthcare Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Middle East Healthcare Company SJSC is 74.02 SAR with a low forecast of 62.62 SAR and a high forecast of 84.21 SAR.

Lowest
Price Target
62.62 SAR
8% Downside
Average
Price Target
74.02 SAR
9% Upside
Highest
Price Target
84.21 SAR
24% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Middle East Healthcare Company SJSC is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Middle East Healthcare Company SJSC stock?

The intrinsic value of one Middle East Healthcare Company SJSC stock under the Base Case scenario is hidden SAR.

Is Middle East Healthcare Company SJSC stock undervalued or overvalued?

Compared to the current market price of 68 SAR, Middle East Healthcare Company SJSC is hidden .

Back to Top